Clinical Cancer Drugs

Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer



Meet Our Editor-in-Chief free to download

Volume:3   Issue: 2
Pp: 75-75
Giulio Francia
DOI: 10.2174/2212697X0302161010231240



Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors open access plus

Volume:3   Issue: 2
Pp: 76-86
Xiao-Yan Zhao, Babu Subramanyam, Nenad Sarapa, Sven Golfier and Harald Dinter
DOI: 10.2174/2212697X03666160218215744




Efficacy of Bacteria in Cancer Immunotherapy: Special Emphasis on the Potential of Mycobacterial Species

Volume:3   Issue: 2
Pp: 100-108
Santosh Podder, Srabanti Rakshit, Manikandan Ponnusamy and Dipankar Nandi
DOI: 10.2174/2212697X03666160824130123




Evaluation of Antitumor Potential of Forskolin and Andrographolide Employing Potato Tumor Bioassay Model

Volume:3   Issue: 2
Pp: 121-130
Velpula Suresh, D. Raju, Rupula Karuna, Godugu Deepika and Sashidhar R. B
DOI: 10.2174/2212697X03666160524161911




Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors open access plus

Volume:3   Issue: 2
Pp: 131-137
G. Steven Martinez, Jeremy A. Ross and Robert A. Kirken
DOI: 10.2174/2212697X03666160610085943




Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells

Volume:3   Issue: 2
Pp: 138-146
Yahaira Santiago-Vázquez, Umashankar Das, Armando Varela-Ramirez, Sarah T. Baca, Yoshira Ayala-Marin, Carolina Lema, Swagatika Das, Alaa Baryyan, Jonathan R. Dimmock and Renato J. Aguilera
DOI: 10.2174/2212697X03666160830165250




ACKNOWLEDGEMENTS TO REVIEWERS free to download

Volume:3   Issue: 2
Pp: 147-147

DOI: 10.2174/2212697X0302161010235347